Hyperthyroidism is the most common endocrine disorder in cats over 10 years old, affecting an estimated 10% of senior cats. Understanding treatment options and quality-of-life management is essential for the welfare of ageing companion cats.
Untreated hyperthyroidism causes progressive deterioration in cat welfare through a combination of metabolic dysregulation, cardiovascular disease, and hypertension-related complications including retinal detachment and blindness. The internal experience of sustained hyperthyroid metabolism — elevated heart rate, muscle weakness, gastrointestinal disturbance, and restlessness — is likely distressing even if outwardly cats appear energetic. Quality-of-life assessment must account for the effect of treatment on concurrent conditions: treating hyperthyroidism can unmask underlying chronic kidney disease that was masked by elevated blood flow, potentially creating a difficult management dilemma. Regular monitoring of thyroid levels, blood pressure, renal function, and cardiac status is essential throughout the treatment period to optimise quality of life.